CorMedix, Inc. (CRMD)
6.46
-0.08
(-1.22%)
USD |
NASDAQ |
Mar 17, 14:53
CorMedix Profit Margin (Quarterly) : 10.90% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | -9.34% |
| Amicus Therapeutics, Inc. | 0.91% |
| ANI Pharmaceuticals, Inc. | 10.28% |
| Castle Biosciences, Inc. | -2.68% |
| Indivior Pharmaceuticals, Inc. | 28.49% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 67.96% |
| Return on Assets | 37.93% |
| Return on Invested Capital | 60.20% |
| Gross Profit Margin (Quarterly) | 83.43% |
| Operating Margin (Quarterly) | 45.97% |
| Return on Net Operating Assets | 56.80% |